EA200702197A1 - Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторы - Google Patents
Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторыInfo
- Publication number
- EA200702197A1 EA200702197A1 EA200702197A EA200702197A EA200702197A1 EA 200702197 A1 EA200702197 A1 EA 200702197A1 EA 200702197 A EA200702197 A EA 200702197A EA 200702197 A EA200702197 A EA 200702197A EA 200702197 A1 EA200702197 A1 EA 200702197A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tractic
- acryloeldystamicine
- receptors
- substituted
- growth factors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к комбинированному применению в лечении опухолей производных акрилоилдистамицина, в частности производных α-бром- и α-хлоракрилоилдистамицина формулы (I), как изложено в описании изобретения, и антитела, ингибирующего фактор роста или его рецептор. Также описано применение упомянутых комбинаций в лечении или профилактике метастазов или в лечении опухолей путем ингибирования ангиогенеза.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05102792 | 2005-04-08 | ||
PCT/EP2006/061153 WO2006108763A1 (en) | 2005-04-08 | 2006-03-29 | Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200702197A1 true EA200702197A1 (ru) | 2008-02-28 |
EA011574B1 EA011574B1 (ru) | 2009-04-28 |
Family
ID=36624474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200702197A EA011574B1 (ru) | 2005-04-08 | 2006-03-29 | Противораковая комбинация, содержащая производные замещённого акрилоилдистамицина и антитела, ингибирующие факторы роста или их рецепторы |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090074757A1 (ru) |
EP (1) | EP1868599B1 (ru) |
JP (1) | JP2008534649A (ru) |
CN (1) | CN101141955A (ru) |
AT (1) | ATE447950T1 (ru) |
AU (1) | AU2006233856A1 (ru) |
BR (1) | BRPI0607499A2 (ru) |
CA (1) | CA2598578A1 (ru) |
CY (1) | CY1109782T1 (ru) |
DE (1) | DE602006010349D1 (ru) |
DK (1) | DK1868599T3 (ru) |
EA (1) | EA011574B1 (ru) |
ES (1) | ES2335805T3 (ru) |
HR (1) | HRP20090617T1 (ru) |
MX (1) | MX2007010525A (ru) |
PL (1) | PL1868599T3 (ru) |
PT (1) | PT1868599E (ru) |
RS (1) | RS51231B (ru) |
SI (1) | SI1868599T1 (ru) |
WO (1) | WO2006108763A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2868791A1 (en) * | 2012-03-30 | 2013-10-03 | The Regents Of The University Of California | Anti-emp2 therapy reduces cancer stem cells |
US10385395B2 (en) | 2012-04-11 | 2019-08-20 | The Regents Of The University Of California | Diagnostic tools for response to 6-thiopurine therapy |
CN109966499A (zh) * | 2019-04-25 | 2019-07-05 | 苏州大学 | 协同增效的抗乳腺癌转移药物组合物及其用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5165922A (en) * | 1990-05-22 | 1992-11-24 | Bristol-Myers Squibb Company | Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
US6150508A (en) * | 1996-03-25 | 2000-11-21 | Northwest Biotherapeutics, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
KR20040078118A (ko) * | 2002-01-02 | 2004-09-08 | 파마시아 이탈리아 에스.피.에이. | 치환된 아크릴로일 디스타마이신 유도체 및 단백질 키나제(세린/트레오닌 키나제) 저해제를 포함하는 항종양 조합요법 |
CA2481005C (en) * | 2002-04-02 | 2009-06-09 | Pharmacia Italia S.P.A. | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
-
2006
- 2006-03-29 EA EA200702197A patent/EA011574B1/ru not_active IP Right Cessation
- 2006-03-29 MX MX2007010525A patent/MX2007010525A/es active IP Right Grant
- 2006-03-29 DK DK06725409.4T patent/DK1868599T3/da active
- 2006-03-29 CN CNA2006800088834A patent/CN101141955A/zh active Pending
- 2006-03-29 AT AT06725409T patent/ATE447950T1/de active
- 2006-03-29 WO PCT/EP2006/061153 patent/WO2006108763A1/en active Application Filing
- 2006-03-29 BR BRPI0607499-5A patent/BRPI0607499A2/pt not_active IP Right Cessation
- 2006-03-29 US US11/887,998 patent/US20090074757A1/en not_active Abandoned
- 2006-03-29 PL PL06725409T patent/PL1868599T3/pl unknown
- 2006-03-29 JP JP2008504744A patent/JP2008534649A/ja not_active Withdrawn
- 2006-03-29 PT PT06725409T patent/PT1868599E/pt unknown
- 2006-03-29 EP EP06725409A patent/EP1868599B1/en active Active
- 2006-03-29 ES ES06725409T patent/ES2335805T3/es active Active
- 2006-03-29 SI SI200630513T patent/SI1868599T1/sl unknown
- 2006-03-29 CA CA002598578A patent/CA2598578A1/en not_active Abandoned
- 2006-03-29 DE DE602006010349T patent/DE602006010349D1/de active Active
- 2006-03-29 RS RSP-2010/0007A patent/RS51231B/sr unknown
- 2006-03-29 AU AU2006233856A patent/AU2006233856A1/en not_active Abandoned
-
2009
- 2009-11-18 HR HR20090617T patent/HRP20090617T1/hr unknown
-
2010
- 2010-02-11 CY CY20101100141T patent/CY1109782T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0607499A2 (pt) | 2009-06-13 |
RS51231B (sr) | 2010-12-31 |
DK1868599T3 (da) | 2010-02-15 |
HRP20090617T1 (hr) | 2009-12-31 |
EP1868599B1 (en) | 2009-11-11 |
US20090074757A1 (en) | 2009-03-19 |
MX2007010525A (es) | 2008-01-16 |
PL1868599T3 (pl) | 2010-04-30 |
JP2008534649A (ja) | 2008-08-28 |
ES2335805T3 (es) | 2010-04-05 |
SI1868599T1 (sl) | 2010-01-29 |
WO2006108763A1 (en) | 2006-10-19 |
EA011574B1 (ru) | 2009-04-28 |
AU2006233856A1 (en) | 2006-10-19 |
EP1868599A1 (en) | 2007-12-26 |
PT1868599E (pt) | 2010-01-26 |
CN101141955A (zh) | 2008-03-12 |
ATE447950T1 (de) | 2009-11-15 |
DE602006010349D1 (de) | 2009-12-24 |
CY1109782T1 (el) | 2014-09-10 |
CA2598578A1 (en) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
EA200701853A1 (ru) | Производные циклопентапиридина и тетрагидрохинолина | |
ATE554087T1 (de) | Neue kinaseinhibitoren | |
EA201000558A1 (ru) | Производные имидазола | |
EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
TW200624426A (en) | BACE inhibitors | |
EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
ATE512151T1 (de) | Pyrrolotriazin-kinaseinhibitoren | |
EA200970207A1 (ru) | Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов | |
EA200901611A1 (ru) | Производные 2-оксо-3-бензил-бензоксазол-2-она и родственные соединения в качестве ингибиторов мет киназы для лечения опухолей | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
ATE527253T1 (de) | Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer | |
EA201170590A1 (ru) | Ингибиторы рецептора фактора роста фибробластов-3 (fgfr-3) и способы лечения | |
WO2007047646A3 (en) | Substituted dihydro-isoindolones useful in treating kinase disorders | |
EA201000550A1 (ru) | Производные тиазола | |
ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
EA200801414A1 (ru) | Кальцилитические соединения | |
EA201000814A1 (ru) | 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств | |
EA201000618A1 (ru) | 5-цианотиенопиридины для лечения опухолей | |
EA200701676A1 (ru) | Производные дигидроимидазотиазола | |
EA200800070A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина | |
DE602006021327D1 (de) | Isochinoline als igf-1r-inhibitoren | |
ATE542796T1 (de) | N-sulfonylcarboximidamidverbindungen als apoptosepromotoren | |
ATE411287T1 (de) | Neue metallproteinaseinhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |